Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thornberry Nancy −$262K Director sold 37% of stake
  2. Schuth Alexander O. −$65K COFO and Secretary sold <1% of stake
  3. Chin Peter Scott −$37K Chief Medical Officer sold <1% of stake

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-12 NELSEN ROBERT Director Conversion · Series B-1 Preferred Stock −312,500 0
2017-12-12 FLATLEY JAY T Director Conversion +250,000 250,000
2017-12-12 FLATLEY JAY T Director Conversion · Series A-1 Preferred Stock −250,000 0

Page 53 of 53 · 1,043 trades